Non-alcoholic steatohepatitis (NASH): Risk factors in morbidly obese patients

International Journal of Molecular Sciences

Volumn 16, Issue 10, 2015, Pages 25552-25559

  Losekann, Alexandre ^a   Weston, Antonio C ^b   De Mattos, Angelo A ^a   Tovo, Cristiane V ^a   De Carli, Luis A ^b   Espindola, Marilia B ^b   Pioner, Sergio R ^b   Coral, Gabriela P ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b Hospital Santa Casa de Misericórdia de Porto Alegre   (Brazil)

Author keywords

Liver fibrosis; Morbidly obese; NAFLD; NASH

Indexed keywords

ASPARTATE AMINOTRANSFERASE; FERRITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ALANINE AMINOTRANSFERASE; GLUCOSE BLOOD LEVEL; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BARIATRIC SURGERY; BIOCHEMICAL ANALYSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; IRON BLOOD LEVEL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; RETROSPECTIVE STUDY; RISK FACTOR; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPLICATION; FIBROSIS; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID;

ADULT; ALANINE TRANSAMINASE; BLOOD GLUCOSE; FEMALE; FIBROSIS; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; TRIGLYCERIDES;

EID: 84945271446     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161025552     Document Type: Article

References (27)

1. Brunt, E.M. Nonalcoholic steatohepatitis. Semin. Liver Dis. 2004, 24, 3–20.
2. White, D.L.; Kanwal, F.; El-Serag, H.B. Associations between nonalcoholic fatty liver disease and risk for hepatocellular cancer based on systematic review. Clin. Gastroenterol. Hepatol. 2012, 10, 1342–1359.
3. Musso, G.; Gambino, R.; Cassader, M.; Pagano, G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 2011, 43, 617–649.
4. Clark, J.M. The epidemiology of nonalcoholic fatty liver disease in adults. J. Clin. Gastroenterol. 2006, 40, 5–10.
5. Zamin, I., Jr.; de Mattos, A.A.; Zettler, C.G. Nonalcoholic steatohepatitis in nondiabetic obese patients. Can. J. Gastroenterol. 2002, 16, 303–307.
6. Ratziu, V.; Giral, P.; Charlotte, F.; Bruckert, E.; Thibault, V. Liver fibrosis in overweight patients. Gastroenterology 2000, 118, 1117–1123.
7. Chalasani, N.; Younossi, Z.; Lavine, J.E.; Diehl, A.M.; Brunt, E.M.; Cusi, K.; Charlton, M.; Sanyal, A.J. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55, 2005–2023.
8. De Andrade, A.R.; Cotrim, H.P.; Alves, E.; Soares, D.; Rocha, R. Nonalcoholic fatty liver disease in severely obese individuals: The influence of bariatric surgery. Ann. Hepatol. 2008, 7, 364–368.
9. Mathurin, P.; Hollebecque, A.; Arnalsteen, L.; Buob, D.; Leteurtre, E.; Caiazzo, R.; Pigeyre, M.; Verkindt, H.; Dharancy, S.; Louvet, A. et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009, 137, 532–540.
10. Moretto, M.; Kupski, C.; da Silva, V.D.; Padoin, A.V.; Mottin, C.C. Effect of bariatric surgery on liver fibrosis. Obes. Surg. 2012, 22, 1044–1049.
11. Mummadi, R.R.; Kasturi, K.S.; Chennareddygari, S.; Sood, G.K. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 2008, 6, 1396–1402.
12. Mosko, J.D.; Nguyen, G.C. Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin. Gastroenterol. Hepatol. 2011, 9, 897–901.
13. Ong, J.P.; Elariny, H.; Collantes, R.; Younoszai, A.; Chandhoke, V.; Reines, H.D.; Goodman, Z.; Younossi, Z.M. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes. Surg. 2005, 15, 310–315.
14. Bedossa, P.; Poitou, C.; Veyrie, N.; Bouillot, J.L.; Basdevant, A.; Paradis, V.; Tordjman, J.; Clement, K. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 2012, 56, 1751–1759.
15. DˈAlbuquerque, L.A.C.; Gonzalez, A.M.; Whale, R.C.; de Oliveira Souza, E.; Mancero, J.M.; de Oliveira e Silva, A. Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery. Liver Transpl. 2008, 14, 881–885.
16. Angulo, P.: Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance? Hepatology 2010, 51, 373–375.
17. Chisholm, J.; Seki, Y.; Toouli, J.; Stahl, J.; Collins, J.; Kow, L. Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery. Surg. Obes. Relat. Dis. 2012, 8, 416–422.
18. Praveenraj, P.; Gomes, R.M.; Kumar, S.; Karthikeyan, P.; Shankar, A.; Parthasarathi, R.; Senthilnathan, P.; Rajapandian, S.; Palanivelu, C.: Prevalence and predictors of non-alcoholic fatty liver disease in morbidly obese south indian patients undergoing bariatric surgery. Obes. Surg. 2015, 25, 2078–2087.
19. Pagano, G.; Pacini, G.; Musso, G.; Gambino, R.; Mecca, F.; Depetris, N.; Cassader, M.; David, E.; Cavallo-Perin, P.; Rizzetto, M. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002, 35, 367–372.
20. Rocha, R.; Cotrim, H.P.; Carvalho, F.M.; Siqueira, A.C.; Braga, H.; Freitas, L.A. Body mass index and waist circumference in non-alcoholic fatty liver disease. J. Hum. Nutr. Diet. 2005, 18, 365–370.
21. Chitturi, S.; Abeygunasekera, S.; Farrell, G.C.; Holmes-Walker, J.; Hui, J.M.; Fung, C. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35, 373–379.
22. Guidorizzi de Siqueira, A.C.; Cotrim, H.P.; Rocha, R.; Carvalho, F.M.; de Freitas, L.A.; Barreto, D.; Gouveia, L.; Landeiro, L. Non-alcoholic fatty liver disease and insulin resistance: Importance of risk factors and histological spectrum. Eur. J. Gastroenterol. Hepatol. 2005, 17, 837–841.
23. Kruger, F.C.; Daniels, C.R.; Kidd, M.; Swart, G.; Brundyn, K.; van Rensburg, C.; Kotze, M. APRI: A simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. South Afr. Med. J. 2011, 101, 477–480.
24. Harrison, S.A.; Oliver, D.; Arnold, H.L.; Gogia, S.; Neuschwander-Tetri, B.A. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008, 57, 1441–1447.
25. Shah, A.G.; Lydecker, A.; Murray, K.; Tetri, B.N.; Contos, M.J.; Sanyal, A.J.; Nash Clinical Research Network. Use of the FIB4 index for non-invasive evaluation of fibrosis in nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2009, 7, 1104–1112.
26. Brunt, E.M.; Janney, C.G.; Di Bisceglie, A.M.; Neuschwander-Tetri, B.A.; Bacon, B.R. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999, 94, 2467–2474.
27. Kleiner, D.E.; Brunt, E.M.; van Natta, M.; Behling, C.; Contos, M.J.; Cummings, O.W.; Ferrell, L.D.; Liu, Y.C.; Torbenson, M.S.; Unalp-Arida, A. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313–1321.